JP2024507827A - 病原性生物を抑制するための組成物及び方法 - Google Patents

病原性生物を抑制するための組成物及び方法 Download PDF

Info

Publication number
JP2024507827A
JP2024507827A JP2023550015A JP2023550015A JP2024507827A JP 2024507827 A JP2024507827 A JP 2024507827A JP 2023550015 A JP2023550015 A JP 2023550015A JP 2023550015 A JP2023550015 A JP 2023550015A JP 2024507827 A JP2024507827 A JP 2024507827A
Authority
JP
Japan
Prior art keywords
clostridium
bacteroides
composition
taurine
pieces
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023550015A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024507827A5 (https=
Inventor
オーレ，ベルナット
カバレロ，シルビア
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vedanta Biosciences Inc
Original Assignee
Vedanta Biosciences Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vedanta Biosciences Inc filed Critical Vedanta Biosciences Inc
Publication of JP2024507827A publication Critical patent/JP2024507827A/ja
Publication of JP2024507827A5 publication Critical patent/JP2024507827A5/ja
Pending legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/095—Sulfur, selenium, or tellurium compounds, e.g. thiols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
JP2023550015A 2021-02-18 2022-02-18 病原性生物を抑制するための組成物及び方法 Pending JP2024507827A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163151003P 2021-02-18 2021-02-18
US63/151,003 2021-02-18
PCT/US2022/017043 WO2022178292A1 (en) 2021-02-18 2022-02-18 Compositions and methods for suppressing pathogenic organisms

Publications (2)

Publication Number Publication Date
JP2024507827A true JP2024507827A (ja) 2024-02-21
JP2024507827A5 JP2024507827A5 (https=) 2025-02-27

Family

ID=80685400

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023550015A Pending JP2024507827A (ja) 2021-02-18 2022-02-18 病原性生物を抑制するための組成物及び方法

Country Status (5)

Country Link
US (1) US20240316119A1 (https=)
EP (1) EP4294413A1 (https=)
JP (1) JP2024507827A (https=)
CN (1) CN117202919A (https=)
WO (1) WO2022178292A1 (https=)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7846613B2 (ja) * 2019-08-09 2026-04-15 ヴェダンタ バイオサイエンシーズ インコーポレーテッド 病原菌を抑制するための組成物及び方法
WO2024160742A1 (en) * 2023-01-30 2024-08-08 Mrm Health N.V. Microbial compositions for treating joint inflammation
EP4438051A1 (en) * 2023-03-28 2024-10-02 Biome Inc. Microbiome-based composition for preventing and treating multidrug resistant bacterial infections
CN118580989B (zh) * 2024-03-07 2025-08-22 江南大学 一种能在非水溶性膳食纤维上形成多菌生物膜的混菌组合及多菌生物膜制备方法
CN118987051A (zh) * 2024-09-13 2024-11-22 南方医科大学南方医院 粪副拟杆菌在制备治疗移植物抗宿主病药物中的应用

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3261761A (en) 1962-05-07 1966-07-19 Arthur W Anderson Method of freeze drying bacterial cultures
US4205132A (en) 1978-07-17 1980-05-27 Microlife Technics, Inc. Lyophilization of bacteria
CS239559B1 (sk) 1983-04-07 1986-01-16 Jozef Rusko Elektrostatická nanášacia kabina
US6368586B1 (en) 1996-01-26 2002-04-09 Brown University Research Foundation Methods and compositions for enhancing the bioadhesive properties of polymers
WO2012098358A1 (en) 2011-01-20 2012-07-26 Biopharma Technology Ltd Freeze drying method
WO2014029578A1 (en) 2012-08-24 2014-02-27 Haldor Topsøe A/S Method and catalyzed filter element with improved alkali-resistance for flue gas cleaning
US10973861B2 (en) * 2013-02-04 2021-04-13 Seres Therapeutics, Inc. Compositions and methods
AU2015244700B2 (en) 2014-04-10 2020-08-27 Riken Compositions and methods for induction of Th17 cells
JP2018519295A (ja) 2015-06-22 2018-07-19 プレジデント アンド フェローズ オブ ハーバード カレッジ 粘膜固有層調節性ｔ細胞の誘導
CA3226196A1 (en) * 2016-06-14 2017-12-21 Vedanta Biosciences, Inc. Treatment of clostridium difficile infection
EP3706767A4 (en) 2017-11-09 2021-12-15 Vedanta Biosciences, Inc. COMPOSITIONS AND METHODS FOR THE TREATMENT OF AN ALLERGY
EP3723776A4 (en) 2017-12-11 2022-07-27 Vedanta Biosciences, Inc. Compositions and methods for suppressing pathogenic organisms
EP3999084A4 (en) * 2019-07-19 2023-07-12 Finch Therapeutics Holdings LLC METHODS AND PRODUCTS FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS

Also Published As

Publication number Publication date
CN117202919A (zh) 2023-12-08
EP4294413A1 (en) 2023-12-27
WO2022178292A1 (en) 2022-08-25
US20240316119A1 (en) 2024-09-26
WO2022178292A9 (en) 2023-06-29

Similar Documents

Publication Publication Date Title
JP7483828B2 (ja) Ｃｌｏｓｔｒｉｄｉｕｍ ｄｉｆｆｉｃｉｌｅ感染症の処置
US20240316119A1 (en) Compositions and methods for suppressing pathogenic organisms
US20250009811A1 (en) Compositions and methods for suppressing pathogenic organisms
US11701396B2 (en) Treatment of Clostridium difficile infection
JP7846613B2 (ja) 病原菌を抑制するための組成物及び方法
CN108289918B (zh) 经巴氏灭菌的艾克曼菌用于治疗代谢病症的用途
Madsen The use of probiotics in gastrointestinal disease
Fernandez et al. Dietary mannan-oligosaccharides and their effect on chicken caecal microflora in relation to Salmonella Enteritidis colonization
Klarin et al. Adhesion of the probiotic bacterium Lactobacillus plantarum 299v onto the gut mucosa in critically ill patients: a randomised open trial
ES3036447T3 (en) New strain of lactobacillus reuteri
HK40114606A (en) Compositions and methods for suppressing pathogenic organisms
HK40104391A (en) Treatment of clostridium difficile infection
HK40007703B (en) Treatment of clostridium difficile infection
HK40007703A (en) Treatment of clostridium difficile infection
Quera et al. Small Intestinal Bacterial Overgrowth: Roles of Antibiotics, Prebiotics, and Probiotics
Penner et al. PREBIOTICS COLITIS IN ULCERATIVE 35

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250218

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20250218

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20260206